Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newspaper Article
|
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera in Stage II Colorectal CancerBusiness Wire, 2024-03-18COPYRIGHT 2024 Business Wire, Inc.Digital Resources/Online E-Resources |
|
2 |
Material Type: Newspaper Article
|
Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic TestingBusiness Wire, 2024-03-05COPYRIGHT 2024 Business Wire, Inc.Digital Resources/Online E-Resources |
|
3 |
Material Type: Newspaper Article
|
Medicare Extends Coverage of Natera's Signatera MRD Test to Ovarian Cancer and Neoadjuvant Breast CancerBusiness Wire, 2024-02-26COPYRIGHT 2024 Business Wire, Inc.Digital Resources/Online E-Resources |
|
4 |
Material Type: Newspaper Article
|
Nature Medicine Publishes Two Studies Highlighting Signatera's Clinical Utility in Patients with Gastrointestinal MalignanciesBusiness Wire, 2024-01-25COPYRIGHT 2024 Business Wire, Inc.Digital Resources/Online E-Resources |
|
5 |
Material Type: Newspaper Article
|
The Worldwide Market for Liquid Biopsy, 6th Edition - ResearchAndMarkets.comBusiness Wire, 2024-01-22COPYRIGHT 2024 Business Wire, Inc.Digital Resources/Online E-Resources |
|
6 |
Material Type: Newspaper Article
|
City of Hope Doctors and Scientists Present Innovative Research at Largest Gathering on Breast Cancer ResearchBusiness Wire, 2023-12-08COPYRIGHT 2023 Business Wire, Inc.Digital Resources/Online E-Resources |
|
7 |
Material Type: Newspaper Article
|
Vizient Explores Cardiac Ablation Modalities, Advancements in Remote Patient Monitoring and Imaging Alternatives for Early Breast Cancer DetectionBusiness Wire, 2023-12-06COPYRIGHT 2023 Business Wire, Inc.Digital Resources/Online E-Resources |
|
8 |
Material Type: Newspaper Article
|
Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast CancerBusiness Wire, 2023-11-08COPYRIGHT 2023 Business Wire, Inc.Digital Resources/Online E-Resources |
|
9 |
Material Type: Newspaper Article
|
Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera in Colorectal CancerBusiness Wire, 2023-07-28COPYRIGHT 2023 Business Wire, Inc.Digital Resources/Online E-Resources |
|
10 |
Material Type: Newspaper Article
|
Natera Announces New Publication from I-SPY2 Trial Reinforcing Clinical Utility of Signatera for Breast Cancer Patients in the Neoadjuvant SettingBusiness Wire, 2023-05-08COPYRIGHT 2023 Business Wire, Inc.Digital Resources/Online E-Resources |
|
11 |
Material Type: Newspaper Article
|
New Publication Demonstrates Utility of Natera's Signatera Test in MelanomaBusiness Wire, 2023-03-22COPYRIGHT 2023 Business Wire, Inc.Digital Resources/Online E-Resources |
|
12 |
Material Type: Newspaper Article
|
American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Now Includes Breast Cancer Index to Guide Decisions about Extended Endocrine TherapyBusiness Wire, 2022-04-25COPYRIGHT 2022 Business Wire, Inc.Digital Resources/Online E-Resources |
|
13 |
Material Type: Newspaper Article
|
City of Hope and Osel Announce Live Biotherapeutic Product CBM588 May Enhance Efficacy of Immunotherapy for Patients With Metastatic Kidney CancerBusiness Wire, 2022-02-28COPYRIGHT 2022 Business Wire, Inc.Digital Resources/Online E-Resources |
|
14 |
Material Type: Newspaper Article
|
Hologic Debuts Documentary-Style Film Highlighting One Woman's Breast Cancer Journey Timed to Breast Reconstruction Awareness DayBusiness Wire, 2021-10-20COPYRIGHT 2021 Business Wire, Inc.Digital Resources/Online E-Resources |
|
15 |
Material Type: Newspaper Article
|
City of Hope and Osel Announce Exclusive License for Intellectual Property on the Use of Live Biotherapeutic Product CBM588 for Oncology Therapeutic ApplicationsBusiness Wire, 2021-07-14COPYRIGHT 2021 Business Wire, Inc.Digital Resources/Online E-Resources |
|
16 |
Material Type: Newspaper Article
|
Study: Testosterone Pellet Therapy Reduces Breast Cancer Incidence in WomenBusiness Wire, 2021-05-11COPYRIGHT 2021 Business Wire, Inc.Digital Resources/Online E-Resources |
|
17 |
Material Type: Newspaper Article
|
City of Hope and San Antonio Regional Hospital to Expand Access to Cancer Care in the Inland EmpireBusiness Wire, 2017-02-01COPYRIGHT 2017 Business Wire, Inc.Digital Resources/Online E-Resources |
|
18 |
Material Type: Newspaper Article
|
Biocon Collaborates with Advaxis for 'ADXS-HPV' A Novel Cancer ImmunotherapyBusiness Wire, 2014-01-22COPYRIGHT 2014 Business Wire, Inc.Digital Resources/Online E-Resources |
|
19 |
Material Type: Newspaper Article
|
BioTime's Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTMBusiness Wire, 2013-01-31COPYRIGHT 2013 Business Wire, Inc.Digital Resources/Online E-Resources |
|
20 |
Material Type: Newspaper Article
|
GE Healthcare to Showcase Innovative Breast Cancer Solutions from Screening through Monitoring at SABCS 2012Business Wire, 2012-12-05COPYRIGHT 2012 Business Wire, Inc.Digital Resources/Online E-Resources |